News

Filter by Category

Filter by Program

Filter by Date

April 8, 2021

CP-SCD Announces Pfizer Executive as its First Industry Co-Director

C-Path’s Critical Path to Sickle Cell Disease Consortium (CP-SCD) is pleased to announce Dr. David Readett of Pfizer as its firs

April 6, 2021

C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science

March 31, 2021

Cures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has a

March 31, 2021

C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera

March 18, 2021

C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Pr

February 17, 2021

The Critical Path Institute Data Collaboration Center is seeking proposals for the creation of non-identifiable, synthetic patient

October 28, 2020

C-Path has signed a Memorandum of Understanding with EATRIS, the European infrastructure for translational medicine, to accelerate

September 9, 2020

C-Path’s Patient-Reported Outcome (PRO) Consortium announced that it has been awarded a U.S. Food and Drug Administration (FDA)

September 3, 2020

C-Path’s Patient-Reported Outcome (PRO) Consortium announced today it has been awarded a U.S. Food and Drug Administratio

August 25, 2020

C-Path’s Crohn's Disease Biomarkers Pre-Consortium funded by The Helmsley Charitable Trust is proud to announce its...